サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1514028

バイオイメージング技術の世界市場

BioImaging Technologies

出版日
ページ情報
英文 174 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
バイオイメージング技術の世界市場
出版日: 2024年07月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 174 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

バイオイメージング技術の世界市場は2030年までに316億米ドルに達する見込み

2023年に119億米ドルと推定されるバイオイメージング技術の世界市場は、2023年から2030年にかけてCAGR 15.0%で成長し、2030年には316億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである医療技術は、CAGR14.7%を記録し、分析期間終了時には195億米ドルに達すると予測されます。分子テクノロジー分野の成長率は、分析期間中CAGR 15.5%と推定されます。

米国市場は33億米ドルと推定、中国はCAGR14.2％で成長予測

米国のバイオイメージング技術市場は2023年に33億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに48億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは14.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ13.0％と12.6％と予測されています。欧州では、ドイツがCAGR 10.7%で成長すると予測されています。

世界のバイオイメージング技術市場- 主要動向と促進要因のまとめ

バイオイメージング技術は、生物学的プロセスをリアルタイムで可視化することで、医学に革命をもたらしました。解剖学的構造情報と、電場や磁場、機械的運動、代謝プロセスなどの機能的データを組み合わせることで、バイオイメージングは人体内部の仕組みを包括的に見ることができます。X線、超音波、MRI、高度なCTスキャンなどの技術は、解剖学的構造や細胞構造の詳細な画像を明らかにし、病気の診断や管理に極めて重要です。これらの非侵襲的な方法は、物理的な侵入なしに詳細な検査を可能にし、臨床現場において非常に貴重なものとなっています。バイオイメージングは、複雑な生物学的問題に取り組むために電気工学、機械工学、生物医学工学を統合した学際的分野であり、がんなどの疾患の理解と治療に大きな進歩をもたらしています。

バイオイメージングの進歩は、計算生物学とバイオインフォマティクスに深く根ざしており、細胞や分子の画像のハイスループット解析に焦点を当てています。最新の自動顕微鏡と高度な計算手法により、人間の介入を最小限に抑えながら、データ解析の精度と効率が向上しています。多光子イメージング、画像誘導インターベンション、様々な顕微鏡技術などの革新は、医療診断や治療計画の能力を拡大してきました。バイオイメージングにおける重要な課題の1つは、画像処理手法の計算の複雑さと並んで、画像再構成に伴う数値的不安定性です。最近の動向には、人工知能（AI）と機械学習を統合して画像解析を強化し、生データを実用的な医療上の洞察に変換することが含まれます。

バイオイメージング技術の成長にはいくつかの重要な要因があります。AIと機械学習の進歩により、より高度な分析が可能になり、診断精度と効率が向上します。強化された計算能力と優れたアルゴリズムにより、より高速で信頼性の高い画像処理が可能になります。個別化医療への要求の高まりにより、個人の生理学的・分子学的プロファイルに基づいた治療法を調整するための高度な画像技術が必要とされています。生物医学研究の拡大には、細胞レベルや分子レベルでの生物学的プロセスの観察と分析が必要であり、高度なイメージングツールの必要性を後押ししています。特に新興国におけるヘルスケア支出の増加がバイオイメージングの採用を後押ししています。早期かつ正確な診断に対する患者の意識の高まりと期待は、規制当局の支援政策やイメージング技術のコスト削減とともに、ヘルスケアにおけるバイオイメージングシステムの普及をさらに促進しています。これらの要因が総合的に、現代の医療・科学領域におけるバイオイメージングの重要な役割を裏付けています。

調査対象企業の例（注目の14社）

  • BioClinica
  • Bracco Imaging SpA
  • Digirad Corporation
  • Esaote SpA
  • Fonar Corporation
  • FUJIFILM SonoSite, Inc.
  • GE Healthcare
  • Hitachi, Ltd.
  • Medtronic, Inc.
  • Philips Healthcare
  • Positron Corporation
  • Siemens Healthineers

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP-7637

Global BioImaging Technologies Market to Reach US$31.6 Billion by 2030

The global market for BioImaging Technologies estimated at US$11.9 Billion in the year 2023, is expected to reach US$31.6 Billion by 2030, growing at a CAGR of 15.0% over the analysis period 2023-2030. Medical Technology, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$19.5 Billion by the end of the analysis period. Growth in the Molecular Technology segment is estimated at 15.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 14.2% CAGR

The BioImaging Technologies market in the U.S. is estimated at US$3.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2030 trailing a CAGR of 14.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.0% and 12.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.7% CAGR.

Global BioImaging Technologies Market - Key Trends and Drivers Summarized

Bioimaging technologies have revolutionized medical sciences by providing real-time visualization of biological processes. Combining anatomical structure information with functional data such as electrical and magnetic fields, mechanical motion, and metabolic processes, bioimaging offers a comprehensive view of the human body's internal workings. Techniques like X-rays, ultrasound, MRI, and advanced CT scans reveal detailed images of anatomical and cellular structures, crucial for diagnosing and managing diseases. These non-invasive methods allow for detailed examination without physical intrusion, making them invaluable in clinical settings. Bioimaging is an interdisciplinary field integrating electrical, mechanical, and biomedical engineering to address complex biological questions, leading to significant advancements in understanding and treating diseases like cancer.

The advancement of bioimaging is deeply rooted in computational biology and bioinformatics, focusing on high-throughput analysis of cellular and molecular images. Modern automated microscopes and sophisticated computational methods enhance the accuracy and efficiency of data analysis with minimal human intervention. Innovations such as multi-photon imaging, image-guided interventions, and various microscopy techniques have expanded the capabilities of medical diagnostics and therapeutic planning. One critical challenge in bioimaging is the numerical instability associated with image reconstruction, alongside the computational complexity of image processing methods. Recent developments include integrating Artificial Intelligence (AI) and machine learning to enhance image analysis, transforming raw data into actionable medical insights.

Several key factors drive the growth of bioimaging technologies. Advancements in AI and machine learning enable more sophisticated analysis, improving diagnostic accuracy and efficiency. Enhanced computational power and better algorithms allow for faster and more reliable image processing. The increasing demand for personalized medicine necessitates advanced imaging technologies to tailor therapies based on individual physiological and molecular profiles. Expanding biomedical research requires observing and analyzing biological processes at cellular and molecular levels, driving the need for advanced imaging tools. Rising healthcare expenditure, particularly in emerging economies, supports the adoption of bioimaging. Higher patient awareness and expectations for early and accurate diagnoses, along with supportive regulatory policies and cost reductions in imaging technology, further promote the widespread use of bioimaging systems in healthcare. These factors collectively underscore the significant role of bioimaging in modern medical and scientific domains.

Select Competitors (Total 14 Featured) -

  • BioClinica
  • Bracco Imaging SpA
  • Digirad Corporation
  • Esaote SpA
  • Fonar Corporation
  • FUJIFILM SonoSite, Inc.
  • GE Healthcare
  • Hitachi, Ltd.
  • Medtronic, Inc.
  • Philips Healthcare
  • Positron Corporation
  • Siemens Healthineers

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • BioImaging Technologies - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Advanced Diagnostic Imaging Techniques
    • Growth of Chronic Diseases and Aging Population
    • Advancements in Imaging Modalities and Technologies
    • Rising Adoption of Molecular Imaging and PET Scans
    • Impact of COVID-19 Pandemic on BioImaging Market
    • Government Regulations and Standards for Medical Imaging Devices
    • Expansion of BioImaging Applications in Drug Discovery and Development
    • Development of AI and Machine Learning in BioImaging Analysis
    • Consumer Preferences for Non-Invasive Diagnostic Procedures
    • Role of BioImaging in Personalized Medicine and Targeted Therapies
    • Market Penetration of BioImaging in Oncology and Neurology
    • Influence of Technological Innovations on BioImaging Accuracy and Speed
    • Growth of BioImaging in Academic and Research Institutions
    • Challenges Related to Data Management and Storage in BioImaging
    • Emerging Markets and Growth Opportunities in Developing Regions
    • Future Trends and Innovations in BioImaging Technologies and Applications
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for BioImaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for BioImaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for BioImaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Molecular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Molecular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Molecular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World BioImaging Technologies Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • CHINA
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for BioImaging Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for BioImaging Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for BioImaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: France 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: UK 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Rest of Europe Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Rest of Europe 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Asia-Pacific 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of World Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of World 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030

IV. COMPETITION